Indogulf Cropsciences (IGCL)₹60.21−1.30%Pesticides & Agrochemicals
At the end of the Jun 2026 quarter, Indogulf Cropsciences' shareholders were: promoters 69.01%, FIIs 0.23%, DIIs 4.34%, public 26.42%. Promoter holding is unchanged on the quarter. FII holding is up 0.23 percentage points from 0.00% a year earlier. It had 23,771 shareholders.
As of · Company filings (shareholding pattern)
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Promoters | 96.82% | 69.01% | 69.01% | 69.01% | 69.01% |
| FIIs | 0.00% | 0.41% | 0.21% | 0.24% | 0.23% |
| DIIs | 0.00% | 6.29% | 4.43% | 4.40% | 4.34% |
| Public | 3.18% | 24.29% | 26.35% | 26.35% | 26.42% |
| Number of shareholders | 28 | 24,801 | 24,870 | 23,870 | 23,771 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Sanjay Aggarwal | Promoter | 20.29% | 0.00 |
| Arnav Aggarwal | Promoter | 13.56% | 0.00 |
| Anshu Aggarwal | Promoter | 13.43% | 0.00 |
| Om Parkash Aggarwal | Promoter | 11.25% | 0.00 |
| Abhiprakash Venture Trust | Promoter | 5.44% | 0.00 |
| Abakkus Diversified Alpha Fund | DII | 4.04% | 0.00 |
| Viney Equity Market Llp | Public | 2.32% | −0.24 |
| Anamica Aggarwal | Promoter | 1.57% | 0.00 |
| Rachita Aggarwal | Promoter | 1.57% | 0.00 |
| Sanshi Aggarwal | Promoter | 1.57% | 0.00 |
| Himanshi Lohia | Public | 1.16% | 0.00 |
| Sanjay Aggarwal Huf | Promoter | 0.40% | 0.00 |
| Om Prakash Aggarwal Huf | Promoter | 0.00% | 0.00 |
Promoters held 69.01% of Indogulf Cropsciences at the end of the Jun 2026 quarter, down 27.81 percentage points from 96.82% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.23% (down 0.01 percentage points from 0.24% a quarter earlier) and domestic institutions (DIIs) held 4.34% (down 0.06 percentage points from 4.40% a quarter earlier).
Indogulf Cropsciences had 23,771 shareholders at the end of the Jun 2026 quarter, against 28 a year earlier.
Abakkus Diversified Alpha Fund (DII) held 4.04% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.